Synbio International Inc. secures rights to conduct clinical trials for AI-powered depression screening technology (NIMS: Non-invasive Mental Screening).NIMS is a fast, highly accurate and cost-effect ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Starting today, people with Parkinson's disease will have a new treatment option, thanks to U.S. Food and Drug Administration approval of groundbreaking new technology.
Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
The FDA approved the sale of Zyn nicotine pouches, which are increasingly popular with teens. But nicotine pouches cause ...
Leerink Partners Global Healthcare Conference, Miami Wednesday, March 12, 2025 (1x1 meetings) The live and archived webcasts will be accessible from the Company’s website at https://brightmindsbio.com ...
Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.
Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...
“This bill would require the Alabama Medicaid Agency to cover screening and would also regulate how Medicaid covers prescription drugs used to treat postpartum depression,” the legislation states.
Researchers have debunked key beliefs about addiction, like that a person must hit "rock bottom" before having treatment or ...
Zoloft (sertraline) has interactions with many types of medications, including other antidepressants, amphetamines, blood ...